{
  "zip": "8952",
  "sector": "Healthcare",
  "fullTimeEmployees": 143,
  "longBusinessSummary": "Molecular Partners AG operates as a clinical-stage biopharmaceutical company. It is developing Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of wet age-related macular degeneration, as well as for diabetic macular edema; and MP0250 that binds and inhibit vascular endothelial growth factor and hepatocyte growth factor pathways, which restores clinical sensitivity to various standard-of-care therapies in multiple myeloma. The company is also developing MP0274 that is in Phase I clinical trials for HER2-positive solid tumors; MP0310, which is in Phase I clinical trials for immuno-oncology; MPO317, a tumor-localized immune agonist that activates immune cells in the tumor; and Peptide-MHC, a tumor-localized immune-cell agonist to attack tumors. It has strategic partnerships with Allergan, Inc. and Amgen SA; and collaboration with AGC Biologics to develop anti-COVID-19 DARPin program. Molecular Partners AG was founded in 2004 and is headquartered in Schlieren, Switzerland.",
  "city": "Schlieren",
  "phone": "41 44 755 77 00",
  "country": "Switzerland",
  "companyOfficers": [],
  "website": "http://www.molecularpartners.com",
  "maxAge": 1,
  "address1": "Wagistrasse 14",
  "fax": "41 44 755 77 07",
  "industry": "Biotechnology",
  "previousClose": 23.2,
  "regularMarketOpen": 23.37,
  "twoHundredDayAverage": 23.44875,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 24,
  "navPrice": null,
  "averageDailyVolume10Day": 3337,
  "totalAssets": null,
  "regularMarketPreviousClose": 23.2,
  "fiftyDayAverage": 23.44875,
  "trailingAnnualDividendRate": null,
  "open": 23.37,
  "averageVolume10days": 3337,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 0.540858,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 23.37,
  "priceHint": 2,
  "currency": "USD",
  "regularMarketVolume": 3923,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 530595520,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 3337,
  "priceToSalesTrailing12Months": null,
  "dayLow": 23.37,
  "ask": null,
  "ytdReturn": null,
  "askSize": null,
  "volume": 3923,
  "fiftyTwoWeekHigh": 24.195,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 23,
  "bid": null,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": null,
  "dayHigh": 24,
  "exchange": "PNK",
  "shortName": "MOLECULAR PARTNERS AG",
  "longName": "Molecular Partners AG",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "MLLCF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_32677064",
  "uuid": "992c585a-515b-3488-bb8f-5990e21df8b2",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 21809600,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": null,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.45106,
  "netIncomeToCommon": null,
  "trailingEps": null,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.15198,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1593475200,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 13532850,
  "enterpriseValue": 505982464,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 23.37,
  "logo_url": "https://logo.clearbit.com/molecularpartners.com"
}